Related Experiment Video
Updated: Dec 11, 2025

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
Cancer Risk by Attained Age among Children with Birth Defects in Arkansas
Jenil Patel1, Jeremy M Schraw2, Philip J Lupo2
1Department of Epidemiology, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR USA; Arkansas Center for Birth Defects Research and Prevention, Fay W. Boozman College of PublicHealth, University of Arkansas for Medical Science, Little Rock, AR USA.
Insights
Children with birth defects, particularly cardiovascular and genitourinary, face the highest risk of pediatric cancer in their first year of life. This highlights the need for targeted surveillance strategies for early detection.
Area of Science:
- Pediatric Oncology
- Birth Defect Research
- Epidemiology
Background:
- Limited research exists on the association between birth defects and pediatric cancer risk across different ages.
- Understanding these associations is crucial for early detection and intervention.
Purpose of the Study:
- To assess pediatric cancer risk in children with and without birth defects, stratified by age at diagnosis.
- To investigate specific birth defect types and their correlation with cancer risk.
Main Methods:
- A cohort study linked data from Arkansas birth records, cancer registries, and birth defect monitoring systems (1996-2011).
- Cox proportional hazards models were used to analyze cancer risk by attained age groups (<1, 1-4, 5-9, 10-14 years).
- Associations were examined between various birth defect categories (any, chromosomal, non-chromosomal) and cancer subtypes.
Main Results:
- The study included 629,086 children, with 3.7% having birth defects and 0.2% diagnosed with cancer.
- Children with non-chromosomal birth defects (cardiovascular, genitourinary) had the highest cancer risk in the first year of life (HR 18.5).
- Children with chromosomal birth defects showed increased cancer risk between 1-4 years old (HR 20.0).
Conclusions:
- Pediatric cancer risk is elevated in children with birth defects, especially those under five years old.
- Findings support the need for enhanced surveillance strategies for infants and young children with birth defects.
- Early identification and monitoring can improve outcomes for children with congenital anomalies and cancer.
Background:
Few studies have evaluated associations between birth defects and risk of pediatric cancers by age of attainment. Therefore, we assessed the risk of cancer among children with and without birth defects by age at attainment.
Methods:
We examined cancer risk in children ≤14 years with and without birth defects born between 1996 and 2011 by linking data from the Arkansas Reproductive Health Monitoring System, Arkansas Central Cancer Registry, and birth certificates. Age of attainment for cancer was calculated as person-years from birth to cancer diagnosis, death, or end of study period, whichever occurred first. Using Cox proportional hazards models, we evaluated associations by attained age groups (<1, 1-4, 5-9, and 10-14 years) between: (1) groups of birth defects (any, chromosomal, and non-chromosomal) and any cancer; (2) non-chromosomal birth defects by organ system and any cancer; and (3) non-chromosomal birth defects and subtypes of cancer.
Results:
In the cohort of 629,086 children, 23,341 (3.7%) children had birth defects and 1,037 (0.2%) children had cancer. For children with non-chromosomal birth defects, specifically cardiovascular and genitourinary, highest risk of any cancer was observed in first year of life (Hazard Ratio [HR] 18.5; 95% confidence interval [CI] 10.1-33.8). For children with chromosomal birth defects, increased cancer risk was observed among those 1-4 years-old (HR 20.0; 95% CI 8.3-48.4).
Conclusion:
Overall, cancer risk among children with birth defects was highest among those <5 years-old. Our findings, consistent with previous studies, may inform surveillance strategies for children with birth defects.
Related Concept Videos
Cancer Prevention
Some...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Teratogenicity
Nondisjunction
Cancers Originate from Somatic Mutations in a Single Cell
Probability Laws

